Business Description
Natera Inc
NAICS : 621511
SIC : 8071
Total Employee Number:
6,140Description
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.53 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -1.05 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 26.89 | |||||
Beneish M-Score | 0.25 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 26.5 | |||||
3-Year EBITDA Growth Rate | 32.7 | |||||
3-Year EPS without NRI Growth Rate | 35.1 | |||||
3-Year Book Growth Rate | 24.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 20.03 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 99.99 | |||||
9-Day RSI | 99.43 | |||||
14-Day RSI | 96.67 | |||||
3-1 Month Momentum % | 17.52 | |||||
6-1 Month Momentum % | 11.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.96 | |||||
Quick Ratio | 2.83 | |||||
Cash Ratio | 1.95 | |||||
Days Inventory | 25.77 | |||||
Days Sales Outstanding | 47.52 | |||||
Days Payable | 18.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.9 | |||||
Shareholder Yield % | 0.29 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 65.07 | |||||
Operating Margin % | -12.97 | |||||
Net Margin % | -9.05 | |||||
EBITDA Margin % | -9.11 | |||||
FCF Margin % | 2.86 | |||||
OCF Margin % | 8.44 | |||||
ROE % | -15.66 | |||||
ROA % | -10.96 | |||||
ROIC % | -31.76 | |||||
3-Year ROIIC % | 38.66 | |||||
ROC (Joel Greenblatt) % | -66.39 | |||||
ROCE % | -17.35 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 14.79 | |||||
PB Ratio | 21.5 | |||||
Price-to-Tangible-Book | 30.12 | |||||
Price-to-Free-Cash-Flow | 517.79 | |||||
Price-to-Operating-Cash-Flow | 175.09 | |||||
EV-to-EBIT | -132.6 | |||||
EV-to-Forward-EBIT | -130.74 | |||||
EV-to-EBITDA | -164.32 | |||||
EV-to-Forward-EBITDA | 3454.28 | |||||
EV-to-Revenue | 14.96 | |||||
EV-to-Forward-Revenue | 13.44 | |||||
EV-to-FCF | 523.23 | |||||
Price-to-GF-Value | 1.31 | |||||
Price-to-Median-PS-Value | 2.16 | |||||
| Price-to-Net-Current-Asset-Value | 47.04 | |||||
| Price-to-Net-Cash | 154.41 | |||||
Earnings Yield (Greenblatt) % | -0.75 | |||||
FCF Yield % | 0.19 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Natera Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 45,744.831 | ||
| EPS (TTM) (MXN) | -30.058 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 96.67 | ||
| 14-Day ATR (MXN) | 3.819862 | ||
| 20-Day SMA (MXN) | 3905 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (MXN) | 3320 - 3905 | ||
| Shares Outstanding (Mil) | 143.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Natera Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Natera Inc Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 16:30 | In 108 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 107 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 16:30 | In 17 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 16 days | ||
| General meeting for 2026 | 2026-06-11 11:30 | 3,860.00 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 16:30 | 3,320.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 3,320.00 (+0.00%) | ||
| Guidance call for 2026 | 2026-03-10 08:00 | 3,690.00 (+0.00%) | ||
| Raymond James 47th Annual Institutional Investors Conference | 2026-03-04 13:05 | 3,690.00 (+0.00%) | ||
| TD Cowen 46th Annual Health Care Conference | 2026-03-03 09:50 | 3,690.00 (+0.00%) |
Show
Entries
Natera Inc Frequently Asked Questions
What is Natera Inc(MEX:NTRA)'s stock price today?
The current price of MEX:NTRA is MXN3905.00. The 52 week high of MEX:NTRA is MXN3905.00 and 52 week low is MXN3320.00.
When is next earnings date of Natera Inc(MEX:NTRA)?
The next earnings date of Natera Inc(MEX:NTRA) is 2026-08-07 Est..
Does Natera Inc(MEX:NTRA) pay dividends? If so, how much?
Natera Inc(MEX:NTRA) does not pay dividend.
Press Release
Articles on Natera Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers